167 related articles for article (PubMed ID: 28970139)
21. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
[TBL] [Abstract][Full Text] [Related]
22. Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases.
Maitra A; Tascilar M; Hruban RH; Offerhaus GJ; Albores-Saavedra J
Am J Surg Pathol; 2001 May; 25(5):595-601. PubMed ID: 11342770
[TBL] [Abstract][Full Text] [Related]
23. DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
Kataoka I; Funata S; Nagahama K; Isogaya K; Takeuchi H; Abe N; Shibahara J
Ann Diagn Pathol; 2020 Feb; 44():151456. PubMed ID: 31862523
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
Pai RK; Mojtahed K; Pai RK
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):133-40. PubMed ID: 21307665
[TBL] [Abstract][Full Text] [Related]
25. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
[No Abstract] [Full Text] [Related]
26. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
28. Yolk Sac Tumor Originating From Cervical Adenocarcinoma: A Case Predominated by Enteroblastic Differentiation.
Liu XL; Ding L; Lu X; Hu YJ; Zhou XL; Lin DL
Int J Gynecol Pathol; 2023 Mar; 42(2):212-216. PubMed ID: 35639370
[TBL] [Abstract][Full Text] [Related]
29. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
30. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
Yin F; Han X; Yao SK; Wang XL; Yang HC
World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
[TBL] [Abstract][Full Text] [Related]
31. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
[TBL] [Abstract][Full Text] [Related]
32. High-grade fetal adenocarcinoma of the lung is a tumour with a fetal phenotype that shows diverse differentiation, including high-grade neuroendocrine carcinoma: a clinicopathological, immunohistochemical and mutational study of 20 cases.
Suzuki M; Yazawa T; Ota S; Morimoto J; Yoshino I; Yamanaka S; Inayama Y; Kawabata Y; Shimizu Y; Komatsu M; Notohara K; Koda K; Nakatani Y
Histopathology; 2015 Dec; 67(6):806-16. PubMed ID: 25851923
[TBL] [Abstract][Full Text] [Related]
33. [Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity].
Oishi C; Baba T; Kubota Y; Shimotsuma Y; Kitamura K; Honma T; Ikegami A; Inokuchi M; Umeda T; Yoshida H; Imawari M
Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):805-12. PubMed ID: 19498312
[TBL] [Abstract][Full Text] [Related]
34. Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
Yamashiro Y; Saito T; Hayashi T; Murakami T; Yanai Y; Tsuyama S; Suehara Y; Takamochi K; Yao T
Histopathology; 2020 Sep; 77(3):492-502. PubMed ID: 32438490
[TBL] [Abstract][Full Text] [Related]
35. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
36. Gastric adenocarcinoma with enteroblastic differentiation should be differentiated from hepatoid adenocarcinoma: A study with emphasis on clear cells and clinicopathologic spectrum.
Kwon MJ; Byeon S; Kang SY; Kim KM
Pathol Res Pract; 2019 Sep; 215(9):152525. PubMed ID: 31301878
[TBL] [Abstract][Full Text] [Related]
37. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
[TBL] [Abstract][Full Text] [Related]
38. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
Ushiku T; Uozaki H; Shinozaki A; Ota S; Matsuzaka K; Nomura S; Kaminishi M; Aburatani H; Kodama T; Fukayama M
Cancer Sci; 2009 Apr; 100(4):626-32. PubMed ID: 19243386
[TBL] [Abstract][Full Text] [Related]
39. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma.
Akazawa Y; Saito T; Hayashi T; Yanai Y; Tsuyama S; Akaike K; Suehara Y; Takahashi F; Takamochi K; Ueyama H; Murakami T; Watanabe S; Nagahara A; Yao T
Hum Pathol; 2018 Aug; 78():79-88. PubMed ID: 29751042
[TBL] [Abstract][Full Text] [Related]
40. Enteroblastic cholangiocarcinoma: An uncommon, underrecognized subtype of bile duct cancer.
Chun J; Moore M; Kelly P; Kanzawa M; Itoh T; Hong SM; Zen Y
Hum Pathol; 2024 Feb; 144():46-52. PubMed ID: 38301963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
